The Josephin domain is a conserved cysteine protease domain found in four human deubiquitinating enzymes: ataxin-3, the ataxin-3-like protein (ATXN3L), Josephin-1, and Josephin-2. Josephin domains from these four proteins were purified and assayed for their ability to cleave ubiquitin substrates. Reaction rates differed markedly both among the different proteins and for different substrates with a given protein. The ATXN3L Josephin domain is a significantly more efficient enzyme than the ataxin-3 domain despite their sharing 85% sequence identity. To understand the structural basis of this difference, the 2.6 Å x-ray crystal structure of the ATXN3L Josephin domain in complex with ubiquitin was determined. Although ataxin-3 and ATXN3L adopt similar folds, they bind ubiquitin in different, overlapping sites. Mutations were made in ataxin-3 at selected positions, introducing the corresponding ATXN3L residue. Only three such mutations are sufficient to increase the catalytic activity of the ataxin-3 domain to levels comparable with that of ATXN3L, suggesting that ataxin-3 has been subject to evolutionary restraints that keep its deubiquitinating activity in check.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039388PMC
http://dx.doi.org/10.1074/jbc.M110.177360DOI Listing

Publication Analysis

Top Keywords

josephin domain
12
crystal structure
8
evolutionary restraints
8
deubiquitinating activity
8
protein atxn3l
8
atxn3l josephin
8
ataxin-3 domain
8
ataxin-3
7
domain
6
atxn3l
6

Similar Publications

Increased level of angiotensin II (Ang II) plays a central role in the development of hypertensive vascular remodeling. In this study, we identified the deubiquitinating enzyme Josephin domain-containing protein 2 (JOSD2) as a protective factor and investigated its molecular mechanism in Ang II-induced vascular remodeling. First, we found that JOSD2 was upregulated in aortic smooth muscle cells, but not in endothelial cells of Ang II-challenged mouse vascular tissues.

View Article and Find Full Text PDF

JOSD2 promotes breast cancer metastasis by deubiquitinating and stabilizing SMAD4.

Biochem Pharmacol

January 2025

Institute of Pharmacology & Toxicology Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Electronic address:

Breast cancer is one of the most common malignant tumors among women worldwide, and its high degree of metastasis significantly impacts treatment effectiveness leading to poor prognosis. The potential molecular mechanisms underlying breast cancer metastasis remain to be further elucidated. In this study, via database analysis, we revealed that the deubiquitinase josephin domain containing 2 (JOSD2) was abnormally amplified in patients with metastatic breast cancer, and was significantly negatively correlated with patient prognosis.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) was a primary cause of cancer-related morbidity and mortality in China. ATXN3 was a deubiquitinase (DUB) associated with spinocerebellar ataxia, widely expressed in the cytoplasm and nucleus of cells in the central nervous system and other tissues. The crucial role of the Hippo pathway in tumorigenesis has been established, among which TAZ served as one of the key molecules.

View Article and Find Full Text PDF
Article Synopsis
  • The ataxin-3 protein features a unique structure with a functional N-terminal Josephin domain and a C-terminal region with ubiquitin interaction motifs, contributing to its role in neurodegenerative diseases like Machado-Joseph disease.
  • Researchers utilized sequence self-homology dot plot analysis and protein comparisons to study the evolution of ataxin-3 across Filozoa, revealing additional ubiquitin-binding motifs and confirming its conserved architecture.
  • Findings included insights into the evolution of ataxin-3, including the discovery of neofunctionalization events that link modifications in its structure to disease mechanisms, emphasizing the potential for new understandings of its molecular interactions.
View Article and Find Full Text PDF

Cardiac hypertrophy leads to myocardial dysfunction and represents a serious threat to global public health security. Deubiquitinating enzymes (DUBs) mainly maintain the stability of substrate proteins and are essential to cardiac pathophysiology. Here, we explored the role and regulating mechanism of a DUB, Josephin domain-containing protein 2 (JOSD2), in cardiac hypertrophy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!